CARLEE MUDD: Open Payments
NPI 1053036632 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 76 payments from 18 companies in 2025. Trend: 2023 $872 · 2024 $1,525 · 2025 $1,281
Food & beverage: $1,263Education: $17
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 20 | $385 |
| GENZYME CORPORATION | 12 | $199 |
| GlaxoSmithKline, LLC. | 11 | $163 |
| Viatris Specialty LLC | 11 | $140 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Verona Pharma, Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Amgen Inc. | 2 | $34 |
| United Therapeutics Corporation | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: Arikayce, DUPIXENT, NUCALA, YUPELRI, Ohtuvayre, Adempas, TEZSPIRE, Tyvaso.
Industry payments across KY — which companies pay providers there.
